APA (7th ed.) Citation

H, W., S, A., HH, L., H, H., F, F., Y, L., . . . Y, W. (2022). Monocytes engineered with iSNAP inhibit human B-lymphoma progression. Bioengineering & translational medicine, 7(2), e10285. https://doi.org/10.1002/btm2.10285

Chicago Style (17th ed.) Citation

H, Wu, et al. "Monocytes Engineered with ISNAP Inhibit Human B-lymphoma Progression." Bioengineering & Translational Medicine 7, no. 2 (2022): e10285. https://doi.org/10.1002/btm2.10285.

MLA (9th ed.) Citation

H, Wu, et al. "Monocytes Engineered with ISNAP Inhibit Human B-lymphoma Progression." Bioengineering & Translational Medicine, vol. 7, no. 2, 2022, p. e10285, https://doi.org/10.1002/btm2.10285.